CD68 and metabolic dysfunction-associated steatohepatitis: In the present study, it was found that the hybrid model of NASH enhances the hepatic CD68+ cell density and p65−NF−κB protein levels in the C57BL/6J strain while increasing the number of casp3+ and Ki67+ hepatocytes in the BALB/c strain.